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Abstract: Two cases of fatal cryptococcosis are described, one of Cryptococcus neoformans infection in a Gilbert’s
potoroo (Potorous gilbertii) and one of Cryptococcus gattii infection in a long-nosed potoroo (Potorous tridactylus).
The diagnoses were conﬁrmed by culture and speciﬁc immunohistochemistry, respectively. The long-nosed potoroo
tested positive using the latex cryptococcal antigen test (LCAT), whereas the Gilbert’s potoroo had a negative LCAT
result despite having advanced disease of some duration. In both cases, the clinical presentation was a progressive
neurologic disease associated with a central nervous system infection. Pulmonary infection was also observed in the
long-nosed potoroo. Speciﬁc treatment with antifungal agents was unsuccessful in the long-nosed potoroo.
Key words: Potoroo, Cryptococcus neoformans, Cryptococcus gattii, itraconazole, marsupial.
INTRODUCTION
With the exception of the koala,15 cryptococcosis
is rarely reported in marsupials, and no cases have
been described in potoroids. Cryptococcosis in
mammals is caused by two species: Cryptococcus
neoformans (var. grubii and var. neoformans) and
Cryptococcus gattii (formerly C. neoformans var.
gattii or Cryptococcus bacillisporus).13 Infection is
acquired from the environment, primarily via in-
halation.
In humans, disease caused by C. neoformans is
classically associated with immunocompromised
individuals, whereas C. gattii usually causes dis-
ease in immunocompetent hosts. In other mammals,
however, both C. neoformans and C. gattii can be-
have as primary pathogens of immunocompetent
hosts.14,15 Common presentations in mammals in-
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clude rhinosinusitis, pneumonia, and disseminated
disease, including meningitis.14
Potoroos are nocturnal marsupial rat kangaroos
belonging to the family Potoroidae. The Gilbert’s
potoroo is Australia’s most critically endangered
mammal.4 Its estimated population size of 30 indi-
viduals is found only within the Two Peoples’ Bay
Nature Reserve, 30 km east of Albany in Western
Australia.5 The mainland subspecies of the long-
nosed potoroo, occurring in southeastern Australia,
is classiﬁed as ‘‘vulnerable’’ in status.4 Perth Zoo
established a long-nosed potoroo colony in 2000 in
order to reﬁne dietary and husbandry requirements
and to develop artiﬁcial insemination procedures
for the closely related Gilbert’s potoroo.11
This case report describes two cases of crypto-
coccosis, a case of C. neoformans infection in a
Gilbert’s potoroo and a case of C. gattii in a long-
nosed potoroo.
CASE REPORTS
Case 1
A male Gilbert’s potoroo pouch young was
brought from the wild with its mother into the cap-
tive breeding colony housed at Two Peoples’ Bay
Nature Reserve in January 1995. In March 1999, it
had a brief sneezing and coughing episode and de-
veloped a hunched appearance. On examination, it
was trembling and appeared painful on palpation of
its lower thoracic/lumbar spine. A tentative diag-
nosis of spinal muscle injury was made, but no
treatment was administered. Respiratory signs abat-
ed, but the animal’s appetite diminished and its
body weight dropped from 1,096 g to 947 g (14%
loss) in 2 wk.
By February 2000, the animal’s body weight had
declined to 863 g, a 21% weight loss from its initial568 JOURNAL OF ZOO AND WILDLIFE MEDICINE
weight at presentation; the animal’s appetite had di-
minished, and another episode of apparent discom-
fort with a hunched appearance was seen. Hema-
tologic and plasma biochemical testing revealed
leukopenia and the presence of intraerythrocytic
Theileria-like organisms. Such organisms had been
seen in the blood of all of the potoroos in the cap-
tive colony and had not been associated with clin-
ical signs (Vaughan, unpubl. data). No treatment
was given and the animal improved over a week
but was seen on one occasion to be circling in its
pen.
The animal’s weight continued to decline. In Au-
gust 2000, at 748 g, 32% below its initial weight,
the potoroo appeared sluggish and was observed
stumbling. It appeared pale, was estimated to be 5%
dehydrated, and was hypothermic (with a rectal
temperature of 32.8C). It was treated with subcu-
taneous 2.5% glucose in 0.9% saline (5% glucose
and 0.9% sodium chloride solution; Baxter Health-
care, Old Toongabbe, New South Wales 2146, Aus-
tralia) over 3 days but further deteriorated and was
not able to use its forelimbs and was seen to inter-
mittently circle and stumble to the left. It had no
withdrawal reﬂex in the left foreleg and marked
atrophy of the left shoulder muscles.
Treatment began with 12.5 mg of amoxicillin/
clavulanic acid (Clavamox, Pﬁzer Animal Health,
West Ryde, New South Wales 2114, Australia), ad-
ministered subcutaneously (s.c.) daily for 3 days,
and 1 mg s.c. norandrosterone laurate (Laurabolin,
Intervet, Victoria 3550, Australia). Subcutaneous
Vitamin B and E and Hartmann’s solution (Baxter
Healthcare) were also administered.
Treatment was continued for 5 days with no clin-
ical improvment. Several attempts at venipuncture
failed, so the potoroo was anesthetized with iso-
ﬂurane for blood collection and whole-body radio-
graphs. The only radiographic abnormality noted
was mild bilateral lucency of the nasal cavity. He-
matology and plasma biochemical analyses were
normal, apart from increased creatine kinase activ-
ity (4991 U/L), which was attributed to prolonged
recumbency. Serum agglutination tests for Toxo-
plasma immunoglobulin G (IgG) and IgM antibod-
ies were negative. Urine dipstick analysis showed
2 glucose and 1 protein.
The potoroo recovered from anesthesia to the
point of ambulation but was later found comatose
and twitching. Horizontal nystagmus was noted.
Diazepam (0.1 mg, administered intramuscularly
[i.m.]) (Pamlin, Parnell Laboratories, Mascot,
New South Wales 2015, Australia) initially seemed
to calm the potoroo, but the convulsions continued.
Further diazepam (0.2 mg i.m.) and dexamethasone
(0.1 mg i.m.) (dexamethasone sodium phosphate
injection, Mayne Pharma, Parkville, Victoria
3052, Australia) were given. At this time, marked
anisocoria and lateral nystagmus were observed.
The potoroo settled but began convulsing again,
and for the next 12 hr the patient was treated reg-
ularly with diazepam to control convulsions. Final-
ly, it was anesthetized again, and blood was col-
lected before the animal was euthanized with intra-
cardiac pentobarbitone. The blood tested negative
in the latex cryptococcal antigen test (LCAT)12 us-
ing a CALAS kit incorporating a pronase pretreat-
ment step (Meridian Bioscience, Cincinnati, Ohio
45244, USA).
Necropsy revealed extensive fat reserves. Stom-
ach contents were stained with blood, and there was
diffuse bleeding from the cardia region. There were
multifocal widespread irregular areas of congestion
in the liver, within which there were focal yellow
areas up to 3 mm in diameter. In the subcutaneous
tissues of the hind legs there was patchy congestion
and hemorrhage, particularly in the muscles around
the sciatic nerve. No gross lesions were noted in
the central nervous system (CNS).
Histopathology revealed severe multifocal gran-
ulomatous meningoencephalomyelitis. Within vac-
uoles in macrophages, there were intracellular
yeast-like bodies with peripheral spaces. There was
considerable variation in the size of these bodies,
with larger bodies of up to 30 m often markedly
distorted (Fig. 1). No obvious budding was identi-
ﬁed. Lesions were widespread in the meninges of
the cerebral cortex and in the subependymal areas
of the lateral ventricles. Particularly prominent in-
ﬂammatory foci were seen in the roof of the fourth
ventricle and around the root of one vestibular
nerve. In the spinal cord at the level of brachial
plexus, a similar lesion obliterated most of the gray
matter. In the white matter of the cord in this region
there was a patchy vacuolar change with occasional
swollen axons. In the cerebellum there was acute
necrosis of numerous Purkinje cells. There were
also moderate acute multifocal hepatic necrosis, su-
perﬁcially localized moderate gastric mucosal ne-
crosis, diffuse acute mild renal tubular necrosis,
mild multifocal membranous glomerulonephritis,
and mild multifocal acute rhinitis. A speciﬁc im-
munohistochemical stain for C. neoformans7
stained the organisms seen in hematoxylin and eo-
sin (H&E) sections.
Case 2
In November 2004, a 4.5-yr-old female long-
nosed potoroo from the Perth Zoo colony presented
with loss of 80 g (27% of its body weight) over a569 VAUGHAN ET AL.—CRYPTOCOCCOSIS IN TWO POTOROO
Figure 1. Cryptococcus neoformans in a Gilbert’s potoroo. Granulomatous inﬂammatory lesion in the spinal cord
with large distorted yeast forms (a). Hematoxylin and eosin (H&E), 400.
6-wk period. This potoroo had a pouch young and
a young at foot, both of which were removed to
minimize further nutritional strain from lactation
and to rule out competition for food with the young
at foot.
In addition to weight loss, early presenting signs
included hind limb weakness, gluteal muscle atro-
phy, and a rough hair coat. Physical examination
under isoﬂurane anesthesia, including dental ex-
amination and whole-body radiographs, did not de-
tect further abnormalities. Hematology and serum
biochemistry were normal, except for a mild hy-
perbilirubinemia. Toxoplasma serum agglutination
testing for IgG and IGM proved negative, and no
evidence of parasitism was detected on fecal ﬂo-
tation. There was little clinical response to empiric
therapy with combined amoxycillin–clavulanic
acid, 12.5 mg, administered s.c. (Clavamox, Pﬁzer
Animal Health), and 25 ml of s.c. ﬂuids (Hartmanns
compound sodium lactate, Baxter Healthcare),
both of which were administered daily for 5 days.
The potoroo’s condition deteriorated over the
subsequent 5 days, and it was again anesthetized
and given intravenous (i.v.) ﬂuids and parenteral
Vitamin B and Vitamin E. Repeat hematology and
serum biochemistry testing revealed no signiﬁcant
ﬁndings. Therapy under general anesthesia was re-
peated the following day, and antibiotic therapy
was changed to enroﬂoxacin (5 mg s.c., s.i.d; Bay-
tril, Bayer Animal Health Pty Ltd., Pymble, New
South Wales 2079, Australia). Meloxicam (0.2 mg
s.c., s.i.d; Metacam, Boehringer-Ingelheim, North
Ryde, New South Wales 2113, Australia) and nor-
androstenolone laurate (1 mg s.c.; Laurabolin, In-
tervet, Victoria 3550, Australia) were also admin-
istered and an indwelling i.v. catheter placed.
Seven days following initial anesthesia, a slight
and progressive head tilt to the right, circling to the
right, and prolonged recumbency became apparent.
Bilateral exopthalmos, visual deﬁcits, and progres-
sive ataxia ensued. The pupils were ﬁxed and di-
lated, and upon ophthalmoscopic examination, ret-
inal hemorrhage and optic neuritis were evident.
Blood was taken for LCAT12 using a CALAS kit570 JOURNAL OF ZOO AND WILDLIFE MEDICINE
Figure 2. A. Retinal hemorrhage and papilloedema was seen associated with optic neuritis. B. Exopthalmos and
ﬁxed dilated pupils were prominent.
incorporating pronase (Meridian Bioscience). Pre-
sumptive treatment for cryptococcosis was initiated
with itraconazole (20 mg/kg s.i.d, by mouth [p.o.];
Sporanox, oral liquid Janssen–Cilag, North Ryde,
New South Wales 2113, Australia). The ocular le-
sions were treated with 0.5% dexamethasone topi-
cal drops, administered four times a day (q.i.d.;
Maxidex, Alcon Laboratories, French’s Forest,
New South Wales 2086, Australia). Enroﬂoxacin
was continued prophylactically in case of second-
ary bacterial infection. The LCAT test result was
positive, with a titer of 1:32. This titer and clinical
signs were consistent with a diagnosis of neural and
ocular cryptococcosis.12
Inappetence continued, necessitating supplemen-
tal syringe feeding. Although the potoroo appeared
brighter in demeanor following the start of antifun-
gal treatment, circling to the right persisted and was
exacerbated by stress. Ocular lesions showed no
improvement. After 1 wk of treatment with itracon-
azole, antifungal therapy was changed to ﬂucona-
zole (10 mg/kg p.o., two times a day [b.i.d.]; Diﬂu-
can, Pﬁzer Animal Health). Additionally, 0.7 mg
of amphotericin B (0.14 ml of the 5 mg/ml Fun-
gizone solution, Bristol–Myers Squibb, Noble
Park, Victoria 3174, Australia) was administered
subcutaneously twice weekly, diluted in 50 ml of
0.45% NaCl and 2.5% glucose (sodium chloride
and glucose solution, Baxter Healthcare).2 The am-
photericin B infusion was administered under an-
esthesia to minimize stress to the animal. No cryp-
tococcal organisms were cultured from nasal ﬂush-
es, and repeat radiographs did not show any evi-
dence of pulmonary involvement.
Ophthalmoscopic examination 25 days following
the initial anesthesia revealed signiﬁcant optic neu-
ritis and absence of the pupillary light reﬂex in the
right eye (Fig. 2). Similar but less severe changes
were present in the left eye. These ﬁndings, com-
bined with the potoroo’s behavior, were consistent
with partial blindness. The ocular dexamethasone
drops were reduced to b.i.d. administration to min-
imize handling. Repeat monitoring of hematology
and serum biochemistry indicated normal renal
function, despite the potentially nephrotoxic effects
of amphotericin B.
A repeat LCAT 40 days after the initial positive
LCAT showed a greatly increased titer of 1:8,192.
Consequently, a decision was made to increase dos-
es of amphotericin B to 0.9 mg per treatment and
to increase the ﬂuconazole to 20 mg p.o., admin-
istered b.i.d.
One week later, polydipsia became evident.
However, there were no other clinical signs or bio-571 VAUGHAN ET AL.—CRYPTOCOCCOSIS IN TWO POTOROO
Figure 3. Cryptococcus gattii in a long-nosed potoroo. Typical soap-bubble lesion in olfactory lobe of the cerebral
cortex. Hematoxylin and eosin (H&E), 400.
chemical evidence of azotemia. Two weeks follow-
ing implementation of the new dosage regimen, the
animal became inappetant. Conjunctivitis devel-
oped in the left eye and was treated with chlor-
amphenicol ointment, administered b.i.d. (Chloro-
mycetin, Pﬁzer Animal Health).
Given the lack of improvement in neurologic sta-
tus and the onset of secondary problems, a decision
was made to euthanize the potoroo. The animal was
anesthetized and then euthanized with i.v. pento-
barbitone (Lethabarb, Virbac Australia, Peakhurst,
New South Wales 2015, Australia).
Histopathology revealed disseminated meningo-
encephalitis, optic neuritis, granulomatous rhinitis,
and pneumonia. Both the respiratory and nervous
tissue lesions had a typical ‘‘soap-bubble’’ appear-
ance, with narrow-necked budding yeast-like bod-
ies (Fig. 3). Cryptococcus gattii was cultured from
the cerebral tissue and from a sample of cerebro-
spinal ﬂuid collected aseptically immediately after
the animal’s death.
DISCUSSION
Some common features are evident in these two
cases, even though two different species of Cryp-
tococcus were involved and although different spe-
cies of potoroo were affected. Severe granuloma-
tous meningoencephalitis was considered to be the
cause of the clinical syndrome in both potoroos,
with lesions in other organs considered secondary.
Hind limb weakness, muscle atrophy, ataxia, and
circling were consistent clinical ﬁndings.Visualdef-
icits were evident in both potoroos, and marked ret-
inal hemorrhage and optic neuritis were seen in the
long-nosed potoroo.
The organisms identiﬁed as C. gattii in lesions
in the long-nosed potoroo had a typical ‘‘soap-bub-
ble’’ appearance, whereas the organisms identiﬁed
as C. neoformans in the Gilbert’s potoroo were few-
er and were embedded in a granulomatous inﬂam-
matory reaction. The organisms in the latter case
were variable in size and often displayed a distorted
appearance. The distortion is likely an artifact of
processing, but was consistent within a number of
sections.
Clinical diagnosis of cryptococcosis was con-
ﬁrmed in the long-nosed potoroo by the positive
LCAT test. Cryptococcosis was suspected because
of the clinical experience gained from handling the
case in the Gilbert’s potoroo.572 JOURNAL OF ZOO AND WILDLIFE MEDICINE
It is likely that in both cases the respiratory tract
was the primary site of infection, following inha-
lation into the lung, with subsequent central ner-
vous and hematogenous dissemination. Alternative-
ly, the episode of respiratory disease in the Gilbert’s
potoroo could possibly have been caused by a pri-
mary cryptococcal rhinitis. However, the lack of
lesions in the nasal cavity and the long period of
time between this episode and the illness preceding
death makes this possibility unlikely.
Cryptococcosis has rarely been reported in mar-
supials other than the koala.1,8,10 Cases of crypto-
coccosis in quokkas (Setonix brachyurus), walla-
bies (species unspeciﬁed), and numbats (Myrme-
cobius fasciatus) were found in the archives of the
Western Australian Department of Agriculture and
Food Animal Health Laboratory, and cases of cryp-
tococcosis in quokkas, a red-necked wallaby (Ma-
cropus rufogriseus banksianus), a dusky antechinus
(Antechinus swainsonii), and a feathertail glider
(Acrobates pygmaeus) were found in the ﬁles of the
Registry of Wildlife Pathology at Taronga Park Zoo
(Rose, pers. comm.). One case of cryptococcal
granulomatous meningitis, optic neuritis, and mul-
tifocal granulomatous encephalitis in a long-nosed
potoroo was also found in the Registry of Wildlife
Pathology at Taronga Park Zoo. This indicates that
cryptococcosis is not uncommon in marsupials. The
low number of cases in potoroids could be a re-
ﬂection of a small sample size, as there are few
potoroos in captivity.
Although it is possible that both species of Cryp-
tococcus can cause disease in immunocompetent
potoroos, immune dysfunction is a possible predis-
posing condition in these cases. A study of myco-
bacterial disease in long-nosed potoroos indicates
that susceptibility to this disease is related to im-
munologic status and/or regulation.15 Studies of im-
munologic function in both the captive breeding
and wild populations of Gilbert’s potoroos are cur-
rently being undertaken to determine whether the
described cases of cryptococcosis are an indication
of immune dysfunction of the population.
The habitat of potoroos should also be consid-
ered a factor that could increase susceptibility to
disease. Wild potoroos, being ground dwellers and
feeding on underground fungus, primarily inhabit
soil substrates, yet they will come into contact with
moist leaf litter containing Eucalyptus sp. and bird
guano. Captive Gilbert’s potoroos housed within
the Two Peoples’ Bay captive breeding facility also
exist primarily on a sand substrate. Sand changes
in the proximal quarter of the enclosures occur
quarterly, as this section of sand is not exposed to
the rain and organic matter can build up in this
area. Three quarters of the enclosure roof consists
of wire mesh and is open to the elements, so pass-
ing birds could defecate through the wire. These
factors may expose the potoroos to infectious prop-
agules, increasing their potential for exposure and
subsequent infection.
Treatment regimes are yet to be established for
cryptococcosis in marsupial species. Amphotericin
B (often combined with 5-ﬂucytosine) is recog-
nized as the gold standard in the treatment of cryp-
tococcosis, owing to the weight of evidence-based
medicine supporting its use and because it is fun-
gicidal rather than fungistatic.3 However, given its
potential for reversible nephrotoxicity, it is usually
reserved for life-threatening cases with CNS in-
volvement and for cases that are unresponsive to
azoles. The decision was made to initially com-
mence treatment with itraconazole, an agent that
could be given orally without recourse to general
anesthesia. However, it soon became clear that it-
raconazole was having little effect in reversing neu-
rologic signs, and therapy was therefore changed to
include the combination of amphotericin B and ﬂu-
conazole. Fluconazole achieves better CNS pene-
tration than itraconazole, with generally fewer side
effects.3 Although the use of 5-ﬂucytosine may
have been helpful, it was not possible to obtain this
agent in a timely fashion or in a suitable formula-
tion.
Historically, amphotericin B has been adminis-
tered i.v. to human, canine, and feline patients.
However, newer subcutaneous infusion methods2
not only slow absorption of the potentially neph-
rotoxic drug and promote diuresis to help minimize
nephrotoxicity but also make administration possi-
ble under manual restraint. The authors have used
this approach in a variety of zoo animals, including
koalas and a cheetah. Although the potoroo still
required light general anesthesia for administration
of amphotericin B, its small size and lack of robust
veins for venipuncture made the s.c. route a prac-
tical route of administration.
In cases involving optic neuritis, many authori-
ties recommend concurrent administration of cor-
ticosteroids. However, owing to the underlying in-
fectious etiology, steroids were initially withheld in
favor of NSAID therapy. Corticosteroids were in-
troduced following the second administration of
amphotericin B, when neurologic signs became
worse immediately following treatment. This phe-
nomenon was thought to be related to the osmotic
effects of polysaccharides released from the dead
fungus and to the inﬂammatory response to the in-
tracellular cryptococcal antigens of the host.2 The
decision was therefore made to premedicate with573 VAUGHAN ET AL.—CRYPTOCOCCOSIS IN TWO POTOROO
dexamethasone (0.5 mg/kg) before subsequent am-
photericin B infusions in order to minimize adverse
neurologic sequelae related to this phenomenon.
Environmental colonization with C. gattii (mo-
lecular type VG1) has been associated with bark
and plant debris from certain eucalyptus species,
including Eucalyptus camaldulensis (river redgum),
Eucalpytus tereticornis (forest redgum), Eucalyptus
grandis (ﬂooded gum), Eucalyptus rudis, and Eu-
calyptus gomphocephala.13–15 One possible source
of contamination of the potoroo enclosures at the
Perth Zoo is the eucalyptus branches that were used
as enclosure furniture. These branches were com-
monly recycled from the zoo’s koala enclosure.
This may be a signiﬁcant factor, since koalas have
been found to be capable of amplifying the number
of cryptococci in their environment.6,9,13 Cryptococ-
cal culture of sand, branches, and leaves from the
koala enclosure is being undertaken to validate this
presumption.
CONCLUSIONS
Cryptococcosis represents a potential threat to
the survival of both the critically endangered Gil-
bert’s potoroo and the vulnerable long-nosed poto-
roo. In species with small population sizes, the ef-
fects of disease can be catastrophic. Over time,
these small populations can also lose genetic vari-
ability as a result of genetic drift and/or inbreeding,
which may in turn increase susceptibility to dis-
ease.5 Cryptococcal screening via nasal swab,
LCAT titers, and environmental sampling should be
considered in captive breeding and translocation
health screening protocols for potoroos.
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